• Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities
  • Adrian M. Di Bisceglie, MD, FACP, and Robert G. Gish, MD, co-chair this free, yearlong CME/CE program featuring the very latest information on screening and current and emerging treatment strategies for HBV management. Get clarity and guidance from prominent hepatology experts on key issues and practice challenges, including how cultural differences can affect physician/patient communications, thus impacting the management of HBV infection. Earn CME/CE credit and complete all courses to earn your Certificate of Advanced Study....more
    • A. Di Bisceglie, MD, FACP
    R. Gish, MD
  • Hepatitis C — Social Media, HCV, and the Gastroenterologist
  • How will scientific and digital advances revolutionize your practice? Join us for a symposium that will explore how the advances now changing the world will transform the practice of gastroenterology and the management of chronic hepatitis C. Dr. Bryan S. Vartabedian, an expert on healthcare and social media, will discuss why new powerful communication and connection technologies on platforms such as Facebook, Twitter, and blogs can be useful to the gastroenterologist, and may increasingly impact patient care. Dr. Ira M. Jacobson, program chair, and our expert faculty, Drs. Hashem B. El-Serag and Donald M. Jensen, will demonstrate how response-guided therapies and emerging targeted agents, within the context of increased societal awareness of hepatitis C, are changing treatment paradigms....more
    • I. Jacobson, MD
  • Hepatitis C — Game Changers in Hepatology—Future Challenges in the Treatment of HCV
  • What will your practice look like in the coming years? Watch Game Changers in Hepatology—Future Challenges in the Treatment of HCV,, an on-demand rebroadcast of a recent CME/CE satellite symposium, chaired by Dr. Ira Jacobson, during which Rosemarie Nelson, a nationally known healthcare consultant, will interpret system-wide changes on the healthcare horizon, such as electronic medical records and new reimbursement structures, for the hepatology practice. Drs. Bruce Bacon and Nezam Afdhal will expand on how increasingly complex therapeutic regimens fit within the new healthcare paradigm.
    ...more
    • I. Jacobson, MD
  • Hepatitis C — Brainstorming with the Experts: Practical Approaches to the Complex World of HCV
  • This stimulating and thought-provoking webcast features a renowned faculty panel—led by Ira Jacobson, MD—who shape their experience and the latest research data into presentations that clarify the state of the science. Moderating is Ira Flatow, host of Talk of the Nation: Science Friday® on National Public Radio, who practices his notable art of transforming science into discussion. The result: science made useable, complexity made manageable....more
    • I. Flatow,
    I. Jacobson, MD
  • Hepatitis B — Expert Insight Into: Efficacy of Antiviral Therapy in Chronic Hepatitis B Patients with Mildly Elevated ALT and Histological Liver Damage (Part 7 of Series)
  • When to initiate treatment for chronic hepatitis B patients with precirrhotic liver disease is currently a matter of debate. Join Dr. Adrian M. Di Bisceglie as he reviews a retrospective analysis of clinical trial data that compared the efficacy of antiviral therapy in patients with mildly elevated ALT to the efficacy in those with ALT levels ≥2 times the upper limit of normal....more
    • A. Di Bisceglie, MD, FACP
  • Hepatitis B — Expert Insight Into: Perinatal Transmission of Hepatitis B Virus: An Australian Experience (Part 6 of Series)
  • Despite the widespread use of active and passive immunization, some risk of perinatal HBV transmission remains. Dr. Pan discusses a recent study of perinatal transmission in an Australian cohort of HBsAg-positive, HBV DNA-positive mothers. The study concluded that HBeAg seropositivity and very high HBV DNA levels were each associated with increased risk of perinatal transmission in spite of active and passive immunization....more
    • C. Pan, MD, FACP, FACG
  • Hepatitis B — Case Study: Focus on Basic Disease Management (the "Grey Zone" Patient)
  • In this case-based e-newsletter, Tram T. Tran, MD, follows the case of a Chinese-born man in his mid-forties who receives a diagnosis of chronic hepatitis B. His serologic, virologic, and biochemical markers at the time of presentation place him in the grey-zone category between “Treat” and “Don’t Treat” according to current treatment guidelines. Join Dr. Tran as she demonstrates the decision-making processes for starting treatment in this patient and for interpreting response as his on-treatment HBV DNA levels fail to become undetectable. This course is part of Advanced Certificate Program V: Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities....more
    • R. Gish, MD
  • Hepatitis C — Social Media, HCV, and the Gastroenterologist
  • How will scientific and digital advances revolutionize your practice? Join us for a symposium that will explore how the advances now changing the world will transform the practice of gastroenterology and the management of chronic hepatitis C. Dr. Bryan S. Vartabedian, an expert on healthcare and social media, will discuss why new powerful communication and connection technologies on platforms such as Facebook, Twitter, and blogs can be useful to the gastroenterologist, and may increasingly impact patient care. Dr. Ira M. Jacobson, program chair, and our expert faculty, Drs. Hashem B. El-Serag and Donald M. Jensen, will demonstrate how response-guided therapies and emerging targeted agents, within the context of increased societal awareness of hepatitis C, are changing treatment paradigms....more
    • I. Jacobson, MD
  • Hepatitis B — Expert Insight Into: Prevalence of Hepatitis B Surface Antigen Among Refugees Entering the United States Between 2006 and 2008 (Part 3 of Series)
  • The CDC recommends testing for chronic HBV infection for all foreign-born individuals from regions with a prevalence rate of 2% or greater, but recent data on the prevalence of HBV are lacking. Dr. Tram Tran discusses a study that provided updated estimates of the prevalence of chronic HBV infection in refugees entering the United States from various countries of origin....more
    • T. Tran, MD
  • Hepatitis B — Expert Insight Into: Hepatitis B Testing and Vaccination Among Vietnamese- and Cambodian-Americans (Part 2 of Series)
  • Owing to the high endemic rate of HBV infection in Southeast Asia, the CDC provides recommendations for HBV testing and vaccination of Southeast Asians living in the United States. Dr. Robert Gish discusses a recent survey that examined rates of HBV testing and vaccination among Vietnamese Americans and Cambodian Americans in four US communities and comments on the need to more effectively reach these populations if prevention and management of HBV are to be improved....more
    • R. Gish, MD
  • Hepatitis B — Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities
  • Adrian M. Di Bisceglie, MD, FACP, and Robert G. Gish, MD, co-chair this free, yearlong CME/CE program featuring the very latest information on screening and current and emerging treatment strategies for HBV management. Get clarity and guidance from prominent hepatology experts on key issues and practice challenges, including how cultural differences can affect physician/patient communications, thus impacting the management of HBV infection. Earn CME/CE credit and complete all courses to earn your Certificate of Advanced Study....more
    • A. Di Bisceglie, MD, FACP
    R. Gish, MD
  • Hepatitis B — Expert Insight Into: Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C (Part 1 of Series)
  • To gain a better understanding of gaps in the effort to reduce and control HBV and HCV infections and to define steps to correct these problems, the Institute of Medicine (IOM) assessed current prevention and control efforts and identified areas for research, policy change, and collaboration between private and public organizations. Based on this assessment, the IOM has recommended changes in four areas — surveillance, knowledge and awareness, immunization, and services for viral hepatitis. Dr. W. Ray Kim comments on these recommendations and suggests steps that community clinicians can take in their own practices to further the goals outlined in this report....more
    • W. Kim, MD
  • Hepatitis C — Game Changers in Hepatology—Future Challenges in the Treatment of HCV
  • What will your practice look like in the coming years? Watch Game Changers in Hepatology—Future Challenges in the Treatment of HCV,, an on-demand rebroadcast of a recent CME/CE satellite symposium, chaired by Dr. Ira Jacobson, during which Rosemarie Nelson, a nationally known healthcare consultant, will interpret system-wide changes on the healthcare horizon, such as electronic medical records and new reimbursement structures, for the hepatology practice. Drs. Bruce Bacon and Nezam Afdhal will expand on how increasingly complex therapeutic regimens fit within the new healthcare paradigm.
    ...more
    • I. Jacobson, MD
  • Hepatitis B — Case Study: HBsAg-Positive, Anti-HBe-Negative Black Immigrant from Somalia
  • Join Dr. W. Ray Kim as he follows the case of an HBV-infected Somali immigrant who is evaluated for antiviral treatment as well as for hepatocellular carcinoma screening. When his patient starts therapy, Dr. Kim uses HBV DNA and ALT levels to determine her response as well as to identify potential adherence issues....more
    • A. Di Bisceglie, MD, FACP